Frequently asked Questions

Global 7 Diagnostics is a high complexity CLIA certified laboratory. Located in Norcross, Georgia, Global 7 started as an Allergy Specialty Laboratory that understood the complex issues that healthcare providers face with allergy testing. We have come a long way since we began in 2015, always with our goal to help the community. Now, we offer allergy and a battery of tests, including COVID-19, RPP, and ARB. At Global 7 we have always strived to be on the leading front of testing and science. This pursuit brought us to be one of the first laboratories to test for SARS-CoV-2 (COVID-19) in Georgia within the first trimester of 2020. Now we are one of the few laboratories testing RT-PCR based on saliva samples.

Our Mission is to provide prompt, high-quality, and comprehensive personalized health care services that are in compliance with government regulations. Global Diagnostics Labs provides innovative laboratory solutions through collaborative partnerships with colleges and universities, private healthcare institutions, and public health organizations. Currently, all of our SARS-Cov-2 (COVID-19) tests have received an Emergency Use Authorization from the United States Food and Drug Administration (FDA).

Our Goal is to empower every medical professional to properly treat, prescribe, and diagnose patient symptoms and conditions by providing our services. We strive to utilize modern technology combined with a clinical methodology to stay ahead of the curve with the fastest turnaround times as possible. At Global 7 Diagnostics Labs, we empower administrators to improve health outcomes for faculty, staff, and the community. Global 7 Diagnostics is a leading clinical laboratory testing with a comprehensive molecular test menu.

Our Promise is to exceed all industry standards and to improve patient care continually. Equally as important as the quality of our services is the integrity with which we conduct our internal business practices and our relationships with ordering physicians and other practitioners.

A novel coronavirus is a new coronavirus that has not been previously identified. The virus causing coronavirus disease 2019 (COVID-19), is not the same as the coronaviruses that commonly circulate among humans and cause mild illness, like the common cold.

Global 7 has been regularly tracking mutations of the coronavirus throughout the pandemic, including a new variant strain of SARS-CoV-2 (VOC 202012/01 or B.1.1.7) in the US, to determine the impact it would have on our PCR test sensitivity. To date, we have not seen any impact. The B.1.1.7 strain is detectable by our current molecular testing.

The virus that causes COVID-19 most commonly spreads between people who are in close contact with one another (within about 6 feet, or 2 arm lengths).

It spreads through respiratory droplets or small particles, such as those in aerosols, produced when an infected person coughs, sneezes, sings, talks, or breathes.

o These particles can be inhaled into the nose, mouth, airways, and lungs and cause infection. This is thought to be the main way the virus spreads. Droplets can also land on surfaces and objects and be transferred by touch. A person may get COVID-19 by touching the surface or object that has the virus on it and then touching their own mouth, nose, or eyes. Spread from touching surfaces is not thought to be the main way the virus spreads.

It is possible that COVID-19 may spread through the droplets and airborne particles that are formed when a person who has COVID-19 coughs, sneezes, sings, talks, or breathes. There is growing evidence that droplets and airborne particles can remain suspended in the air and be breathed in by others, and travel distances beyond 6 feet (for example, during choir practice, in restaurants, or in fitness classes). In general, indoor environments without good ventilation increase this risk.

COVID-19 seems to be spreading easily and sustainably in the community (“communityspread”) in any affected geographic areas. Community spread means people have been infected with the virus in an area, including some who are not sure how or where they became infected.

Community spread means people have been infected with the virus in an area, including some who are not sure how or where they became infected. Each health department determines community spread differently based on local conditions. For information on community spread in your area, please visit your health department’s website

People with COVID-19 have reported a wide range of symptoms – from mild symptoms to severe illness. Symptoms may appear 2-14 days after exposure to the virus. If you have fever, cough, or other symptoms, you might have COVID-19.

It is not yet determined what level of antibodies (to the SARS-CoV-2 spike protein) correlate to immunity against developing symptomatic SARS-CoV-2 disease. Studies are underway to measure the quantitative levels of specific SARS-CoV-2 antibodies following vaccination. Such studies will provide valuable insights into the correlation between protection from vaccination and antibody levels.

Global 7 currently offers several options for COVID-19 tests that identify if individuals are infected or may have been infected with coronavirus. If you are experiencing symptoms of COVID-19, please contact your healthcare provider.

The Centers for Disease Control and Prevention (CDC) recommends that you contact your healthcare provider if you are experiencing symptoms such as fever, cough and shortness of breath; if you’ve been in contact with a person who has COVID-19; or if you have traveled recently from an area with sustained, ongoing transmission.

The current average time to deliver results for the COVID-19 swab test is 24 hours from the date of specimen is received by the lab. For the COVID-19 IgG antibody test, the average delivery of test results is 24-48 hours from the date of specimen is received by the lab.

Global 7 will bill public and private payers for the cost of the testing, and consumers do not incur upfront costs for the test. Physician fees are separate and charged to the consumers by the doctor, telemedicine or healthcare provider.

The list price for COVID-19 molecular diagnostic testing performed by Global 7 is (Prices may vary depending on type of test e.g. PCR Saliva Direct, Nasal Swab, Antigen, Antibody and business type Schools, College/University, Corporations, Doctor’s Offices (Speak to a sales agent for detailed pricing.

Global 7 accepts direct to business agreements, credit card payments, insurance billing and CARERS ACT.

Visit the Centers for Disease Control and Prevention (CDC) website to learn more about how COVID-19 spreads and how to protect yourself.

Visit the website of the Centers for Disease Control and Prevention (CDC) website for the most-current information. Your state and local health authorities are also good sources of information.